Page 197 - Read Online

The neuroimaging characteristics of anti-GABA-B REFERENCES
encephalitis were nonspecific, nearly half of which
might present unilateral or bilateral FLAIR and T2 1. Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J,
hyperintensity in the medial temporal lobe, sometimes Friedman D, Skeen MB, Grisold W, Kimura A, Ohta K, Iizuka T,
Guzman M, Graus F, Moss SJ, Balice‑Gordon R, Dalmau J.
in cerebellum or brain stem which corresponded to the Antibodies to the GABA (B) receptor in limbic encephalitis with
symptoms. Previous reports found that the severity of seizures: case series and characterisation of the antigen. Lancet
clinical symptoms was not associated with the lesion Neurol 2010;9:67‑76.
size on brain image, nor was the presence or absence 2. Scanziani M. GABA spillover activates postsynaptic GABA (B)
receptors to control rhythmic hippocampal activity. Neuron
of underlying tumors. [1] 2000;25:673‑81.
3. Benarroch EE. GABA receptors: structure, functions, and clinical
Regardless of being paraneoplastic or not, most of the implications. Neurology 2012;78:578‑84.
patients developed substantial or full neurological 4. Höftberger R, Titulaer MJ, Sabater L, Dome B, Rózsás A, Hegedus B,
Hoda MA, Laszlo V, Ankersmit HJ, Harms L, Boyero S, de Felipe A,
responses to immunotherapy, including steroids, IVIg, Saiz A, Dalmau J, Graus F. Encephalitis and GABAB receptor
and plasma exchange. In paraneoplastic cases, however, antibodies: novel findings in a new case series of 20 patients.
patients might achieve neurological improvement Neurology 2013;81:1500‑6.
with successful anti-tumor treatments even without 5. Mundiyanapurath S, Jarius S, Probst C, Stöcker W, Wildemann B,
Bösel J. GABA‑B‑receptor antibodies in paraneoplastic brainstem
immunotherapy. In addition, the duration of disease encephalitis. J Neuroimmunol 2013;259:88‑91.
[4]
and clinical outcomes varied depending on the 6. Kim TJ, Lee ST, Shin JW, Moon J, Lim JA, Byun JI, Shin YW, Lee KJ,
presence or absence of SCLC. In our case, the clinical Jung KH, Kim YS, Park KI, Chu K, Lee SK. Clinical manifestations
and neuroimaging characteristics recurred without and outcomes of the treatment of patients with GABAB encephalitis.
J Neuroimmunol 2014;270:45‑50.
detection and treatment of SCLC, which emphasized 7. Boronat A, Sabater L, Saiz A, Dalmau J, Graus F. GABA (B)
the importance of early identification of underlying receptor antibodies in limbic encephalitis and anti‑GAD‑associated
tumors. neurologic disorders. Neurology 2011;76:795‑800.
8. Dogan Onugoren M, Deuretzbacher D, Haensch CA, Hagedorn HJ,
Halve S, Isenmann S, Kramme C, Lohner H, Melzer N, Monotti R,
In conclusion, anti-GABA-B receptor encephalitis is a Presslauer S, Schäbitz WR, Steffanoni S, Stoeck K, Strittmatter M,
potentially treatable disorder that should be diagnosed Stögbauer F, Trinka E, von Oertzen TJ, Wiendl H, Woermann FG,
by autoantibodies tests. Aggressive immunotherapy is Bien CG. Limbic encephalitis due to GABAB and AMPA receptor
often effective, but anti-tumor therapy is also pivotal antibodies: a case series. J Neurol Neurosurg Psychiatry 2014 ; [doi:
for the neurological recovery and long-term outcomes 10.1136/jnnp‑2014‑308814].
of patients with the paraneoplastic event. This case
report joined to the previously reported description Cite this article as: Liu KQ, Yan SQ, Lou M. Gamma-aminobutyric-acid-B
receptor antibodies in limbic encephalitis with small cell lung cancer.
of this paraneoplastic syndrome, [1,4] to delineate the Neuroimmunol Neuroinflammation 2015;2(3):187-9.
importance of early diagnosis for the prognosis and Source of Support: Nil. Conflict of Interest: No.
management. Received: 28-02-2015; Accepted: 23-04-2015

188 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 189